Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by CHUNSHENG KANG
Combination Treatment With Doxorubicin and microRNA-21 Inhibitor Synergistically Augments Anticancer Activity Through Upregulation of Tumor Suppressing Genes
International Journal of Oncology
Cancer Research
Oncology
Upregulation of miR-20a and miR-106b Is Involved in the Acquisition of Malignancy of Pediatric Brainstem Gliomas
Oncology Reports
Medicine
Cancer Research
Oncology
Related publications
The Multi-Kinase Inhibitor Ec-70124 Synergistically Increased the Anti-Tumor Activity of Doxorubicin in Sarcomas
International Journal of Cancer
Cancer Research
Oncology
Anti-Tumor Activity of Selective Inhibitor of Nuclear Export (SINE) Compounds, Is Enhanced in Non-Hodgkin Lymphoma Through Combination With mTOR Inhibitor and Dexamethasone
Cancer Letters
Cancer Research
Oncology
Incorporation of Doxorubicin in Different Polymer Nanoparticles and Their Anticancer Activity
Beilstein Journal of Nanotechnology
Electronic Engineering
Materials Science
Nanoscience
Electrical
Nanotechnology
Astronomy
Physics
The Oncogenic MicroRNA-21 Inhibits the Tumor Suppressive Activity of FBXO11 to Promote Tumorigenesis
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
574. Combination Anticancer Therapy of Doxorubicin and siRNA by Acid-Labile Polymer-Based Cationic Liposomes
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Doxorubicin Induces Cardiotoxicity Through Upregulation of Death Receptors Mediated Apoptosis in Cardiomyocytes
Scientific Reports
Multidisciplinary
Identification of microRNA-21 Target Genes Associated With Hair Follicle Development in Sheep
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
Anticancer Opportunity Created by Loss of Tumor Suppressor Genes
Technology in Cancer Research and Treatment
Medicine
Cancer Research
Oncology
Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway
Frontiers in Oncology
Cancer Research
Oncology
